TIME Exercise/Fitness

Free Phone Apps Count Steps As Accurately As Pricy Fitness Bands

Runner wearing smartphone on arm in city
Getty Images

As a new generation of tech tracks physical activity more accurately, the key will be in motivating users to keep going

You don’t need a specialized fitness monitor to track how far you walk each day. Step and activity tracking apps are multiplying to take advantage of movement sensors already inside smartphones. But can these free apps track step counts as well as a $99 bracelet monitor?

Yes, according to a new study published in JAMA. With more than half of Americans carrying smartphones—versus about 1 percent wearing specialized activity trackers such as those made by Fitbit or Jawbone—researchers think tapping into these apps could help many more people get active.

For the study, researchers outfitted 14 healthy adult volunteers with 10 different tracking methods: smartphones in each pocket running four different apps, three belt-clip pedometers and three wrist-based fitness bands. Each tech-laden volunteer then walked on a treadmill while researchers manually counted their steps.

“Most of these devices are accurate,” says Mitesh Patel, an assistant professor of medicine at the University of Pennsylvania’s Pearlman School of Medicine and coauthor of the new report. He and his colleagues hope the “findings help reinforce individuals’ trust in using smartphone applications and wearable devices,” they note in the paper.

But not all trackers reported identical results. The biggest outlier was Nike’s Fuelband, which tended to count fewer steps (as much as 20 percent less) than were actually taken. The iPhone 5’s Moves app was more likely to report additional steps. Closest to the accurate number were the pedometers Fitbit One and Fitbit Zip.

Despite these slight differences, Patel says, “if someone wants to know whether they’re active, these [all] do the job.”

Tripping up trackers

Pedometers, which clip onto the waistband at the hip, have been the gold standard for accurately counting steps both in and out of the lab, says Greg Welk, an associate professor of kinesiology at Iowa State University, who was not involved in the new study. But these pods failed to really catch on with consumers.

When companies began moving the counters to more familiar zones—like the wrist, via bracelets and watches—and integrating more information, user-friendly interfaces and more social sharing, millions more people signed on.

The integration of step counters into smartphone apps represents an even bigger opportunity to make activity monitoring more widespread. And in Patel’s small study, the apps actually outperformed wrist-based trackers in accuracy. That finding, however, might be due to the fact that volunteers wore the phones in their pants pockets, close to the hips where stride movements are more distinct than they are on the wrist. In the real world, of course, smartphones are not shoved into a pocket and ignored all day.

Which gets to a big problem in this research, which “still doesn’t answer the question of how accurate these things are in the setting where they are meant to be used,” says Ray Browning, associate professor in Colorado State University’s health and exercise science department. That is, outside of slow, deliberate treadmill walking. In the case of the smartphone, he wonders, will apps measure steps as accurately if the phone is carried in a bag, in hand for typing or up to the ear for talking? Patel agrees that his findings are limited: “We don’t know what’s going to happen when people get out in the real world and move around.”

And for many people, walking is not their only daily activity. “The challenge really is when people are doing things other than walking,” Browning says. Many current step trackers will miss exercise from a bike ride, yoga, gardening or elliptical trainers, he notes.

Motivation to move

The broader goal of step counters is to help people be more active. An element of quantification—and competition—might the first step in helping someone choose to walk to a nearby restaurant for lunch rather than drive, Browning says.

While trackers dial up their accuracy, motivation is becoming the next frontier. “We’re still trying to figure out how to transfer [activity data] into long-term behavior change,” Browning says. Improvements could come in the form of more engaging platforms, different types of competitions, financial incentives from employers, doctor referrals or well-timed text messages. Ideas from behavioral economics, for example, could help people get and stay motivated, Patel and his colleagues noted in a JAMA op-ed last week.

Despite small variances in steps counted, if you stick with one monitor, it is likely going to be consistent to you, says Welk, whose 2014 paper on wearable fitness monitors examined discrepancies in calorie estimates. Reflecting relative changes in your activity and behavior, he says, is the real power of these tools.

TIME

New Access To Experimental Drugs For Terminally Ill Patients

The Right to Try act in Colorado will help very sick people get access to some drugs before they're approved by FDA

Very sick people in Colorado have new options as of this past weekend. A state law passed on Saturday gives terminally ill patients the ability to seek experimental treatments that have yet to be approved by the U.S. Food and Drug Administration. And with FDA approval averaging 11 to 14 years for a new drug, skipping the wait could mean a lot for someone who has only months to live.

The “Right to Try Act”—the very first to pass in the U.S.—was signed into law by Colorado’s governor after passing the state legislature unanimously. Similar bills are coming up for approval in Arizona, Louisiana, and Missouri. Each bill would allow patients, in partnership with their physicians, to request experimental medications that are still being tested.

“This is such a paradigm shift for how we approach terminally ill patients’ access to medication in this country,” says Lucy Caldwell, communications director for the conservative public policy and advocacy organization Goldwater Institute, which is behind the current bills.

More from Prevention: Alternatives For The Top 10 Prescribed Medications

Nationwide, people with a terminal illness for which available treatments aren’t working can seek a Compassionate Use Exemption to be included in a clinical trial of a drug or procedure that might help them. Of the 550 requests the FDA received for such exceptions during the 2013 fiscal year, all were approved. “The FDA is strongly supportive of the appropriate use of expanded access,” says Sandy Walsh, a spokesperson for the agency. But many complain that the process is long and mired in paperwork. The new law would allow terminally ill Colorado patients to request treatments without any special exemptions or enrollment in a trial.

Critics of the legislation note that the FDA approval process exists to protect patients from harm, and that true “miracle” drugs are few and far between. Colorado patients will have access to drugs that have passed “Phase 1″—known as the safety phase—of clinical trials. The treatments need not have passed subsequent tests to show whether they are effective or safe in a larger population.

More from Prevention: 20 Ways To Lower Your Cancer Risk

Some 30% of drugs that begin the approval process pass the first phase of clinical trials (which usually include a very small numbers of patients—often between 20 and 80). But only 8% ultimately win approval, and far fewer are truly lifesaving. Some critics worry that opening up unapproved drugs for use will undermine the standards and safeguards the government has put in place to keep patients from needless suffering.

“The FDA has not taken a position on any particular ‘Right to Try’ bill,” says Walsh. “However, the agency is concerned with any efforts that would be inconsistent with its Congressionally mandated authority to protect the public from therapies that are not safe and effective.”

In Colorado, drug companies are under no obligation to provide the drugs, and patients may have to pay for them out of pocket.

“We don’t know what the level of efficacy is going to be—that’s where they’re rolling the dice,” Caldwell says of people who might request experimental drugs. But she notes that for terminally ill patients, side effects might be of little concern: “There’s a side effect that’s certain if I don’t take this drug,” she says. “And that’s death.”

More from Prevention: Measles Vaccine Cures Woman Of Cancer

The article was written by Katherine Harmon Courage and originally appeared on Prevention.com

 

 

TIME

80% of Meat Labels Could Be Meaningless, Exclusive Report Says

Humane Meat Labels
Rubberball/Mike Kemp via Getty Images USDA failed to verify some label claims on store-bought meat

A new report by the advocacy group Animal Welfare Institute finds that "sustainably produced" claims on meat and poultry packages lack transparency, suggesting there are big gaps in verifying that animals are raised humanely

A new report finds that the government was unable to provide proof that many meat and poultry producers are living up to many of their feel-good labeling claims.

The advocacy group Animal Welfare Institute spent three years requesting documentation from the USDA about companies that boast their animals are well cared for or raised in accordance with high environmental standards. The USDA failed to supply documentation supporting these sorts of claims—which range from “Humanely Raised and Handled” to “Sustainably Farmed”—for 20 of the 25 products AWI investigated.

The findings suggest that whether or not the animals in question are actually being raised humanely or in an eco-friendly manner, there are big gaps in verifying those claims and giving consumers access to that information. “We’re not suggesting that all these claims are misleading or that the claims we reviewed were misused,” says Dena Jones, manager of AWI’s Farm Animal Program. “But that’s the problem—we don’t know,” she notes. “That doesn’t give any assurance to the consumer.”

In the five cases in which AWI did receive relevant documents about labeling claims, the evidence, in Jones’s opinion, was inadequate, often consisting of a one- or two-sentence statement by the company that the animals were being raised appropriately—and no additional information about animal cage size, feed or water quality.

These claims are considered added value, Jones says, and people pay top dollar because of them. For example, the online grocery service FreshDirect sells its own brand of boneless, skinless chicken breast cutlets—raised without antibiotics—for $6.99 per pound, whereas they sell a humanely raised and organic competitor’s cutlets for $11.99 per pound. And if the explosion of the organic market is any indication, these claims could be poised to bring in even more sales; in 2013, organic foods soared in size, to approximately $35 billion. “To most people, these claims mean you are getting something above the standard of conventional industry.” And with such prices at stake, companies should have to prove it, she says.

Indeed, these labels have become a major selling point with consumers. “The larger conventional meat companies, they see the success that our sector has had,” says Christopher Ely, co-founder and farmer liaison for Applegate, which makes meat and dairy products, many of which are certified organic. And they want a piece of the warm-and-fuzzy meat pie. “Everybody is jumping in.”

Many companies do pay an outside organization, such as Certified Humane or Global Animal Partnership, to supply guidelines and perform audits to make sure their practices are in line with the statements on their labels. (The third-party labels that AWI cites as trustworthy are Animal Welfare Approved, American Humane Certified, Certified Humane, Food Alliance, USDA Certified Organic and GAP, which verifies products sold at Whole Foods Markets.) But other companies may feel empowered to make exaggerated—or very vague—claims, Jones notes, and the various certification groups have distinct standards for what many of these terms require.

“There aren’t scientifically established and consumer-agreed-upon definitions for ‘humanely raised’ or ‘sustainably raised’,” says Lindy Miller, an agricultural extension educator at Perdue University. “So it becomes very hard to write or enforce regulations.” This leaves the marketplace in moderate chaos—as it was a couple decades ago for the term “organic” before the USDA took over a centralized labeling program. Simply arriving at a unified definition of organic took years and resulted in hundreds of pages of regulatory documents. Terms such as “humane” and “sustainable” are far murkier, and open to interpretation. “It’s not like ‘cage-free’ or ‘free-range,'” which have relatively specific, self-explanatory implications, says Jones.

Applegate was one of the 20 companies for which the USDA failed to supply any documentation supporting a “humanely raised” label. Jones points out that the company had previously verified that claim through Certified Humane but no longer does. Ely explains that Applegate now allows its individual producers to select their certification process but assures that each of its producers does get verified for humane handling. (He also asserts that they file thorough documentation with the USDA each time they apply for a new product label to be approved.)

Ensuring accountability for how an animal was raised becomes even more complicated because the company requesting USDA label approval is rarely the same one that has actually raised the animal. Most major distributors buy their animals from suppliers all over the country. Applegate, for example, might acquire animals from 1,500 different individual farms this year alone, Ely notes. And the USDA, which is tasked mainly with ensuring that food is safe and unadulterated, “does not have authority to regulate animal-raising facilities,” says Catherine Cochran, a USDA spokesperson, adding that they do “require processors to substantiate that they meet the claims presented on their product labels.”

And just because the USDA was not able to supply AWI with documentation does not mean that it does not exist. As Miller notes, when proprietary information—such as a company’s list of suppliers or their animal feed blend—does not generate a human safety concern, the USDA will respect the company’s trade secrets and not release the documents to the public. This policy, he notes, could be adding to the confusion and lack of transparency about how these claims are being verified.

Nevertheless, AWI plans to submit a petition Wednesday to request that the USDA require third-party certification for all labeling claims about sustainability and animal welfare.

“In the end,” says Ely, “it’s going to be about the trust of the label and the company.”

Your browser is out of date. Please update your browser at http://update.microsoft.com